의약품 안전관리 선진화를 위한 한국의약품안전관리원의 역할
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정수연 | - |
dc.contributor.author | 정선영 | - |
dc.contributor.author | 신주영 | - |
dc.contributor.author | 박병주 | - |
dc.date.accessioned | 2024-01-08T06:32:45Z | - |
dc.date.available | 2024-01-08T06:32:45Z | - |
dc.date.issued | 2012-09 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.issn | 2093-5951 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/69366 | - |
dc.description.abstract | Pharmacovigilance is defined as the science and activities relating to the detection, assessment,understanding and prevention of adverse effects or any other drug-related problem. The Korea Institute of Drug Safety and Risk Management (KIDS) was established in April 2012. The main missions of the KIDS are to collect, analyze, evaluate, and manage adverse drug reaction (ADR) data, develop drug utilization review (DUR) criteria, distribute medication guidelines for health professionals, perform retrospective DUR, and perform causality assessment on ADRs, or signals derived from spontaneous reporting or other sources. The KIDS aims to provide evidence to enhance national health quality through a better drug safety and risk management system in Korea. The purpose of this paper is to suggest possible approaches and the KIDS’s role in strengthening the pharmacovigilance system in Korea. | - |
dc.format.extent | 8 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한의사협회 | - |
dc.title | 의약품 안전관리 선진화를 위한 한국의약품안전관리원의 역할 | - |
dc.title.alternative | The role of the KIDS for enhancing drug safety and risk management in Korea | - |
dc.type | Article | - |
dc.identifier.doi | 10.5124/jkma.2012.55.9.861 | - |
dc.identifier.bibliographicCitation | 대한의사협회지, v.55, no.9, pp 861 - 868 | - |
dc.identifier.kciid | ART001695653 | - |
dc.description.isOpenAccess | Y | - |
dc.citation.endPage | 868 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 861 | - |
dc.citation.title | 대한의사협회지 | - |
dc.citation.volume | 55 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Pharmacovigilance | - |
dc.subject.keywordAuthor | Pharamcoepidemiology | - |
dc.subject.keywordAuthor | Drug utilization review | - |
dc.subject.keywordAuthor | Risk management | - |
dc.subject.keywordAuthor | 약물감시 | - |
dc.subject.keywordAuthor | 약물역학 | - |
dc.subject.keywordAuthor | 약물사용평가 | - |
dc.subject.keywordAuthor | 위해관리 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kciCandi | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.